A detailed history of Aull & Monroe Investment Management Corp transactions in Novartis Ag stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 3,841 shares of NVS stock, worth $395,891. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,841
Previous 3,841 -0.0%
Holding current value
$395,891
Previous $408,000 8.09%
% of portfolio
0.21%
Previous 0.2%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$92.57 - $107.37 $46,285 - $53,685
-500 Reduced 11.52%
3,841 $408,000
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $3,220 - $3,574
-34 Reduced 0.78%
4,341 $442,000
Q2 2022

Aug 08, 2022

SELL
$80.52 - $93.75 $4,026 - $4,687
-50 Reduced 1.13%
4,375 $370,000
Q4 2021

Feb 02, 2022

BUY
$79.7 - $88.13 $7,970 - $8,813
100 Added 2.31%
4,425 $387,000
Q1 2021

Apr 19, 2021

SELL
$83.5 - $98.47 $12,525 - $14,770
-150 Reduced 3.35%
4,325 $370,000
Q3 2020

Nov 02, 2020

SELL
$82.14 - $91.0 $16,428 - $18,200
-200 Reduced 4.28%
4,475 $389,000
Q2 2020

Jul 28, 2020

BUY
$80.93 - $91.1 $4,046 - $4,555
50 Added 1.08%
4,675 $408,000
Q1 2020

Apr 22, 2020

SELL
$70.67 - $99.01 $14,134 - $19,802
-200 Reduced 4.15%
4,625 $381,000
Q3 2019

Oct 30, 2019

BUY
$85.54 - $94.26 $412,730 - $454,804
4,825 New
4,825 $419,000
Q2 2019

Jul 29, 2019

SELL
$75.4 - $92.8 $371,345 - $457,040
-4,925 Closed
0 $0
Q1 2019

Apr 18, 2019

SELL
$75.32 - $86.15 $26,361 - $30,152
-350 Reduced 6.64%
4,925 $473,000
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $22,098 - $24,606
-300 Reduced 5.38%
5,275 $453,000
Q3 2018

Oct 31, 2018

BUY
$66.94 - $77.43 $6,694 - $7,743
100 Added 1.83%
5,575 $480,000
Q2 2018

Jul 24, 2018

SELL
$64.91 - $73.36 $12,982 - $14,672
-200 Reduced 3.52%
5,475 $413,000
Q1 2018

May 10, 2018

BUY
$70.39 - $84.15 $14,078 - $16,830
200 Added 3.65%
5,675 $459,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,475
5,475 $457,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Aull & Monroe Investment Management Corp Portfolio

Follow Aull & Monroe Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.